Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems
Central Nervous System
0301 basic medicine
570
functional modulation
Medical Biotechnology
Genetic Vectors
610
PNS
non-human primate
Rodentia
cross-species
Transduction
Mice
03 medical and health sciences
Genetic
Transduction, Genetic
Genetics
Psychology
Animals
0303 health sciences
Neurology & Neurosurgery
Biomedical and Clinical Sciences
General Neuroscience
Pain Research
Neurosciences
Gene Transfer Techniques
AAV
Gene Therapy
Genetic Therapy
Dependovirus
gene therapy
Macaca mulatta
functional readout
Rats
3. Good health
Neurological
Biological psychology
Cognitive Sciences
CNS
Biotechnology
DOI:
10.1016/j.neuron.2022.05.003
Publication Date:
2022-05-27T14:48:09Z
AUTHORS (18)
ABSTRACT
Gene therapy offers great promise in addressing neuropathologies associated with the central and peripheral nervous systems (CNS and PNS). However, genetic access remains difficult, reflecting the critical need for the development of effective and non-invasive gene delivery vectors across species. To that end, we evolved adeno-associated virus serotype 9 (AAV9) capsid in mice and validated two capsids, AAV-MaCPNS1 and AAV-MaCPNS2, across rodent species (mice and rats) and non-human primate (NHP) species (marmosets and rhesus macaques). Intravenous administration of either AAV efficiently transduced the PNS in rodents and both the PNS and CNS in NHPs. Furthermore, we used AAV-MaCPNS1 in mice to systemically deliver the following: (1) the neuronal sensor jGCaMP8s to record calcium signal dynamics in nodose ganglia and (2) the neuronal actuator DREADD to dorsal root ganglia to mediate pain. This conclusively demonstrates the translatability of these two systemic AAVs across four species and their functional utility through proof-of-concept studies in mice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (83)
CITATIONS (92)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....